Article Details
Retrieved on: 2024-09-15 17:12:08
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses long-term results from studies on pembrolizumab's effectiveness versus ipilimumab for melanoma treatment. Key concept 'biotech' is highlighted through advances in cancer immunotherapy impacting progression-free survival and overall survival rates. Tags focus on related drugs, conditions, and key figures, including Caroline Robert.
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here